Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-20-004203
Filing Date
2020-12-08
Accepted
2020-12-08 17:00:57
Documents
1
Period of Report
2020-12-04

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3813
  Complete submission text file 0001683168-20-004203.txt   5325
Mailing Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701
Business Address 40 SPEEN STREET, SUITE 102 FRAMINGHAM MA 01701 781-778-7720
Xenetic Biosciences, Inc. (Issuer) CIK: 0001534525 (see all company filings)

EIN.: 452952962 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 99 HAYDEN AVENUE, SUITE 230 LEXINGTON MA 02421
Business Address
Callaway James Eric (Reporting) CIK: 0001715787 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37937 | Film No.: 201376001